business news in context, analysis with attitude

The American Association of Retired Persons (AARP) says that it will work to convince US pharmaceutical companies not to oppose the growing practice of reimportation, which has US citizens bringing in less expensive prescription medicines from outside the country.

"It's a fact of life -- people go to Canada, they go to Mexico" because they can't afford steep drug prices here, said William Novelli, the AARP CEO. "This is a national embarrassment that Americans have to go abroad to be able to afford their drugs."

AARP apparently is concerned by companies' efforts to shut off the supply of medicines to Canadian companies that are shipping them to the US.
KC's View:
Of course, AARP has another little problem - reimportation is, according to the US Food and Drug Administration (FDA), illegal.

But the assumption seems to be that if you can influence the drug companies, the FDA will back off.

Which is, by itself, troubling.